Background: The objective of this study is to describe the short-term change observed in CGM-related measures and relevant clinical variables in individuals with type 1 diabetes transitioning to ...
Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. An updated algorithm for the Omnipod 5 automated insulin ...
New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...
The Omnipod 5 hybrid closed-loop insulin delivery system worn on the back of an arm. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new ...
Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.
The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...
A medical device correction has been initiated for 3 million continuous glucose monitors. Certain Freestyle Libre 3 systems may provide incorrect low glucose readings, which can lead to serious health ...
Hear from Dr. Bob Gabbay, endocrinologist, researcher, and former Chief Scientific and Medical Officer of the American Diabetes Association, as he explores the most exciting topics and latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback